Why the study?
Does renal denervation provide safe and sustained blood pressure reductions and preserve kidney function in hypertensive patients?
Does renal denervation provide safe and sustained blood pressure reductions and preserve kidney function in hypertensive patients?
Real-world data from the Global SYMPLICITY Registry indicates that renal denervation provides safe and sustained reductions in blood pressure up to 3 years in hypertensive patients.
Supports sustained BP reductions with renal denervation in real-world hypertension; leaves open randomized confirmation of long-term efficacy and safety.
Long-term data from the Global SYMPLICITY Registry representing the largest available cohort of hypertensive patients receiving RDN in a real-world clinical setting demonstrate both the safety and efficacy of the procedure with significant and sustained office and ambulatory BP reductions out to 3 years.
No takes yet. Share an insight, caveat, or question.
Mahfoud et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: